All weekly reports
The 10 Most Shorted ASX Stocks · Week 42, 2020
Weekly Short Selling Report
12 Oct 2020 — 16 Oct 2020
By Shorted AI Research · Published · Sourced from official ASIC short position reports (T+4 delay). Methodology · Not financial advice.
Stocks Shorted
609
Most Shorted
14.79%
WEB
Trading Days
5
Daily Snapshots
Top Shorted Stocks This Week
#
Stock
Short %
1
WEB
Webbeds Group · Consumer Services
14.79%
2
SDA
Speedcast Int
10.58%
3
IVC
Invocare
10.02%
4
MYR
Myer Holdings · Consumer Discretionary Distribution & Retail
9.42%
5
MSB
Mesoblast · Pharmaceuticals, Biotechnology & Life Sciences
9.17%
6
ING
Inghams Group · Food, Beverage & Tobacco
8.65%
7
GXY
Galaxy Resources
8.56%
8
FLT
Flight Centre Travel Group · Consumer Services
8.28%
9
CUV
Clinuvel Pharmaceuticals · Pharmaceuticals, Biotechnology & Life Sciences
7.64%
10
MTS
Metcash · Consumer Staples Distribution & Retail
7.18%
Financial Snapshot
Key financial metrics from recent company reports for the most shorted stocks.
WEBWebbeds GroupAppendix 4E and Annual Report (2026-05-27)
Ebitda: $148.4M(FY26)
Ebitda: $148.4M(FY26)
Eps: 23.8c(FY26)
Eps: 23.8c(FY26)
IVCInvocareHY23 Financial Results (2023-08-28)
Ebitda: $52.187M(six months ended 30 June 2023)
Eps: 3.1c(six months ended 30 June 2023)
MYRMyer HoldingsAppendix 4E - Annual Financial Report (FY26) (2026-09-23)
Dividend: 1.5c(52 weeks ended 25 July 2026)
Ebitda: $413.5M(52 weeks ended 25 July 2026)
Eps: -16.0c(52 weeks ended 25 July 2026)
Net Profit: $-276.5M(52 weeks ended 25 July 2026)
MSBMesoblastAnnual Report to Shareholders (2026-10-12)
Revenue: $120.3M(full year ended 30 June 2026)
INGInghams Group2026 Annual Report (2026-10-09)
Dividend: 10.1c(full year ended 30 June 2026)
Ebitda: $186.4M(full year ended 30 June 2026)
Net Profit: $34.6M(full year ended 30 June 2026)
FLTFlight Centre Travel GroupAppendix 4E and FY26 Annual Report (2026-08-26)
Dividend: 12.0c(year ended 30 June 2026)
Dividend: 30.0c(year ended 30 June 2026)
Ebitda: $430.562M(year ended 30 June 2026)
Ebitda: $465.928M(year ended 30 June 2026)
CUVClinuvel PharmaceuticalsAppendix 4E and Annual Report to Shareholders 2026 (2026-08-27)
Dividend: 2.4 A fully franked final dividend of $0.05 per ordinary sha(full year ended 30 June 2026)
Net Profit: $33.917M(full year ended 30 June 2026)
Revenue: $94.024M(full year ended 30 June 2026)
MTSMetcashAnnual Report to shareholders (2026-08-07)
Dividend: 18.0c(year ended 30 April 2026)
Ebitda: $761.7M(year ended 30 April 2026)
Eps: 25.4c(year ended 30 April 2026)
Net Profit: $279.1M(year ended 30 April 2026)
Track the live rankings on the most shorted ASX stocks page, watch short squeeze candidates, or see market-wide totals in the ASX short selling statistics.
Data sourced from ASIC short position reports (T+4 delayed). This report is for informational purposes only and does not constitute financial advice. Short selling data may not reflect real-time market conditions.